NVO

Novo Nordisk Stock Price

72.17
0.66 (0.92%)
Upgrade to Real-Time
Afterhours (Closed)
72.17

Low
60.31

52 Week Range

High
75.8601

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Novo Nordisk NVO NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.66 0.92% 72.17 20:00:00
Open Price Low Price High Price Close Price Prev Close
72.19 71.91 72.41 72.17 71.51
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,270 1,320,611 $ 72.19 $ 95,338,660 1,059,584 60.31 - 75.8601
Last Trade Time Type Quantity Stock Price Currency
19:00:00 40,568 $ 72.17 USD

Novo Nordisk Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 166.80B 2.31B 2.31B $ 19.92B $ 6.90B 2.46 26.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 1.24 1.72% - -

more financials information »

Novo Nordisk News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NVO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week70.0372.4169.2970.57843,3482.143.06%
1 Month70.8572.4166.5968.87843,6671.321.86%
3 Months72.1375.860166.5971.241,001,0420.040.06%
6 Months70.4875.860163.2270.101,063,1421.692.4%
1 Year61.2375.860160.3167.871,109,91510.9417.87%
3 Years49.7875.860141.22955.541,418,46222.3944.98%
5 Years55.6675.860130.8949.231,721,95416.5129.66%

Novo Nordisk Description

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.


Your Recent History
NYSE
NVO
Novo Nordi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.